The Pregnancy Test Kits Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market size of pregnancy test kits has seen stable growth in recent years. The market size increased from $1.8 billion in 2024 to $1.89 billion in 2025, showing a compound annual growth rate (CAGR) of 4.7%. This is the historical growth trend for the Pregnancy Test Kits Global Market Report 2025 market.
The global market for pregnancy test kits is predicted to expand to a value of $2.41 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.3%.
Download Your Free Sample of the 2025 Pregnancy Test Kits Market Report and Uncover Key Trends Now!The key drivers in the pregnancy test kits market are:
• Emerging pharmacological treatments in the field
• Increased use of telepsychiatry services
• Focus on managing comorbidities
• Global mental health initiatives and awareness programs
The pregnancy test kits market covered in this report is segmented –
1) By Type: Blood Test For Human Chorionic Gonadotropin (HCG), Urine Test For Human Chorionic Gonadotropin (HCG)
2) By Distribution Channel: Retail, Online
3) By Application: Hospitals, Clinics, Households, Pharmacies
4) By End-Users: Professionals, Home-Based
The key trends in the pregnancy test kits market are:
• There is an upcoming trend of emerging pharmacological treatments in the pregnancy test kits market.
• Telepsychiatry services are beginning to shape the future of the market.
• Increasing focus on comorbidities is a noticeable trend.
• The adoption of digital mental health interventions is an emerging trend.
Major companies in the pregnancy test kits market are:
• F. Hoffmann-La Roche Ltd.
• Sanofi S.A
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories
• GlaxoSmithKline PLC
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH.
• Baxter Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• H. Lundbeck A/S
• Shionogi & Co Ltd.
• Recordati S.p.A
• Neurocrine Biosciences Inc.
• Neuraxpharm
• Actavis Plc.
• Noven Pharmaceuticals Inc.
• Sumitomo Pharma Co. Ltd.
• VistaGen Therapeutics
• Valeant Pharmaceuticals International Inc.
• LIFECARE NEURO PRODUCTS LTD.
North America was the largest region in the panic disorders market in 2024